rewrite this title Apple Watch Hypertension Alert Feature Receives FDA Approval

The hypertension alert feature, introduced with the Apple Watch Series 11 and coming to older models, has received FDA approval. Apple says the high blood pressure notifications will be available in over 150 countries.

The Apple Watch Series 11 and Apple Watch Ultra 3 are launching with a hypertension notifications feature. However, like the sleep apnea notifications, this feature needs FDA approval to be offered to users. That approval has now been officially granted.

To Be Launched in Over 150 Countries

Apple states that hypertension notifications, also known as high blood pressure notifications, will be available worldwide in over 150 countries and regions, including the US, EU, Hong Kong, and New Zealand, next week.

Currently, if you look at the technical specifications page for the new Apple Watch models, the word “hypertension” is not mentioned in , while in the US, hypertension notifications are listed among the health and wellness features. The Apple press page also does not mention the hypertension feature. However, this does not mean the feature will be unavailable. The sleep apnea notification feature also came to Turkey at a later date.

High Blood Pressure Notifications Will Also Come to Older Models

The new hypertension notifications feature will also be available on older models like the Apple Watch Series 9, Apple Watch Series 10, and Apple Watch Ultra 2 with the watchOS 26 update. watchOS 26 will be released on September 15th.

How Does the Apple Watch Hypertension Alert Feature Work?

Hypertension notifications use the Apple Watch’s optical heart sensor to analyze blood vessel responses over 30 days and alert users to signs of chronic high blood pressure. Apple says this condition affects about 1.3 billion adults worldwide and is often undiagnosed due to a lack of symptoms.

Apple states that it developed this technology using machine learning and training data from studies involving over 100,000 participants. The company says it validated the technology in clinical trials with over 2,000 participants and expects the feature to send notifications to more than 1 million people with undiagnosed hypertension in its first year. Users who receive a notification are advised to follow the guidelines and track their blood pressure for seven days using a third-party cuff and share the results with a healthcare professional.

You Might Also Like;

Copy URL
URL Copied